US › Healthcare

AptarGroup Inc (ATR)

US · Healthcare · Medical Instruments & Supplies

$136.18-0.43%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$982.9M
Revenue YoY
+10.8%
Net profit
$72.7M
Profit YoY
-7.8%
EPS
$1.19
EPS estimate
$1.15
Net margin
7.4%

EPS came in at 1.19 against a street estimate of 1.15 — a beat of 3.5%.

Key statistics

Market cap
$8.73B
P/E
24.6
Forward P/E
17.4
P/B
3.25
Book value
$41.33
EPS (TTM)
$5.55
Dividend yield
1.41%
52-week high
$145.82
52-week low
$102.07
50-day MA
$123.03
200-day MA
$125.24
Beta
0.38

Analyst view

Analysts rate AptarGroup Inc a buy (5 buy, 2 hold, 0 sell out of 7) with an average price target of $165.43.

Shareholding

Insiders
0.88%
Institutions
97.14%

Largest institutional holders

FundStake
Vanguard Group Inc10.84%
BlackRock Inc9.53%
State Farm Mutual Automobile Ins Co7.43%
Vanguard Portfolio Management, LLC5.90%
Morgan Stanley - Brokerage Accounts5.29%
Vanguard Capital Management, LLC4.52%
State Street Corp4.36%
Victory Capital Management Inc.3.79%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for AptarGroup Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.